Yanhe Technology focuses on individualized genetic testing of tumors: obtained round-round financing of RMB 128 million

Yihe (Beijing) Technology Co., Ltd. (abbreviation: Yihe Technology) won the B round of RMB 128 million financing in early 2017. The lead party is to clear the ginkgo, and the investors are Zhengxin Valley Innovation Capital, Kaifeng Venture Capital and Yahui. Precision Medical Fund, Zehou Capital, etc. Yihe Technology also won the angel investment of Kaifeng Venture Capital; from the end of 2015 to the beginning of 2016, Yihe Technology won the more than 20 million yuan A round of financing led by Yifuze.

Founded in November 2014, Yihe Technology is mainly based on the high-throughput sequencing technology platform, providing cyclic tumor DNA detection, engaging in non-invasive individualized precision diagnosis and treatment, accompanying diagnosis and monitoring of tumor mutation load during the course of disease. At present, the cancer species targeted by Yanhe Technology mainly include lung cancer, colon cancer, liver cancer, breast cancer, etc. It mainly provides cooperation with hospitals to provide tumor gene detection services for patients. Now there are dozens of projects underway, and the sample size has exceeded. Ten thousand pieces.

It is reported that the three core management personnel of Yanhe Technology graduated from Peking University. After graduating from the Department of Biology at Peking University, the founder and CEO of the company, he has many years of experience in investment, pharmaceutical and second-generation sequencing reagent companies and has many years of experience in corporate strategic development management.

臻和科技专注肿瘤个体化基因检测:获B轮1.28亿元融资

Chief Medical Officer Zhang Henghui graduated from the Peking University School of Medicine. He received his Ph.D. in immunology from Capital Medical University. He worked in Peking University People's Hospital and Peking University Institute of Liver Diseases for more than 10 years in clinical and scientific research. As the project leader and co-head, Zhang Henghui was responsible for the preclinical development and research of a number of cancer therapeutic vaccines and molecular diagnostic projects.

Chief Technology Officer Wang Haibo graduated from the Department of Biology of Peking University and went to the United States for more than ten years of research in tumor signaling pathways and molecular biology. He has extensive frontier research and clinical experience and was a senior associate professor at the Cincinnati Children's Hospital Cancer Center in the United States.

Malignant tumors are diseases that seriously threaten human health and social development. According to the latest data released by the World Health Organization, 8.8 million people die every year from cancer worldwide, accounting for nearly one-sixth of the total annual deaths worldwide. The incidence of malignant tumors in China is generally above average. With the aging of the population and social and economic development, the process of industrialization and urbanization is accelerating, environmental factors and lifestyles are constantly changing, and the situation of cancer prevention and control in China is severe.

Yanhe Technology focuses on individualized genetic testing of tumors and hopes to provide accurate medical care for cancer patients. In an interview with a billion-dollar reporter on January 20, 2017, Duhe, CEO of Yihe Technology, said that the tumor is essentially a mutation in the DNA of tumor cells. In the field of tumor detection and treatment, traditional imaging tests can only detect advanced tumors that have already been produced. Only when ctDNA is combined with sequencing can the whole process of the tumor be interpreted in real time and comprehensively, and personalized diagnosis and treatment can be done. . After the B round of financing, Du Bo said that he will continue to focus on scientific research and clinical, and will expand more channels.

Frozen Squid Tentacles

Frozen squid tentacles are the arms or tentacles of a squid that have been frozen for preservation. Squid tentacles are commonly used in cooking and are popular in many cuisines around the world. They can be grilled, fried, sautéed, or used in soups and stews. Frozen squid tentacles are convenient to use as they can be stored in the freezer for an extended period and can be thawed and cooked as needed. They are also a good source of protein and low in fat, making them a healthy addition to any meal.

Zhoushan Fudan Tourism CO., LTD , https://www.fudanfood.com